


The fund aims to produce a rising income with capital growth from a portfolio primarily made up of investments in the UK including ordinary shares, convertibles and fixed interest securities.
| Name | % Net Assets | 
|---|---|
| BP | 5.0% | 
| HSBC | 4.9% | 
| GlaxoSmithKline | 4.5% | 
| Vodafone | 3.3% | 
| Royal Dutch Shell 'B' | 3.2% | 
| Legal & General Group | 3.1% | 
| Rio Tinto | 3.1% | 
| BT | 2.9% | 
| Reed Elsevier | 2.8% | 
| Centrica | 2.5% | 
| Key | % Net Assets | 
|---|---|
| 5.0% | |
| 4.9% | |
| 4.5% | |
| 3.3% | |
| 82.3% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 281.75p | 
| Currency | GBP | 
| Change | 1.21p | 
| % | 0.43% | 
| YTD change | 31.34p | 
| YTD % | 12.52% | 
| Fund Inception | 06/06/2000 | 
|---|---|
| Fund Manager | Adrian Frost / Adrian Gosden | 
| TER | 1.55 (31-May-2012) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | £1,000 | 
| Savings | £50 | 
| Charges | |
|---|---|
| Initial | 5.25% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.15 | 
You are here: research